Table 2

Participants' characteristics at baseline.

Parameter

WBV+

Control N = 11

pb

pc


Initial Randomisation (N = 13)

Reassessed at 6 weeks (N = 10)


Gender (M/F)

5/8

4/6

4/7

-

-

Age (years)

76.6 ± 11.8

76.3 ± 9.7

78.6 ± 10.4

.943

.849

Weight (kg)

63.5 ± 14.3

66.7 ± 13.8

63.2 ± 21.1

.898

.592

Height (m)

1.61 ± 0.12

1.63 ± 0.09

1.63 ± 0.09

.787

.987

BMI (kg/m2)

24.3 ± 3.7

25.1 ± 3.8

25.2 ± 5.5

.776

.557

Waist-Hip index

0.92 ± 0.09

0.92 ± 0.09

0.91 ± 0.11

.459

.557

Whole-body muscle mass (kg)

24.5 ± 6.4

25.7 ± 5.6

27.1 ± 9.2

.691

1

Diagnoses (number)

3.2 ± 1.0

3.1 ± 1.0

2.9 ± 0.8

.502

.725

Medications (number)

5.6 ± 1.7

5.8 ± 1.6

4.7 ± 1.7

.227

.164

OA/B a (number)

10/3

7/3

8/3

-

-


aADL-category according to Katz et al. [13]. Mann-Whitney U Test (exact 2-tailed significance) Control versus WBV+ binitial randomisation creassessed at 6 weeks. Values represent number or mean ± SD.

Bautmans et al. BMC Geriatrics 2005 5:17   doi:10.1186/1471-2318-5-17

Open Data